Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Medicine composition for treating community-acquired pneumonia

A technology for acquired pneumonia and composition, applied in the directions of drug combination, active ingredients of heterocyclic compounds, pharmaceutical formulations, etc., can solve the problems of high price of drugs, great harm to liver and kidney, large side effects, etc., and achieves low cost and small toxic and side effects. , the effect of short course of treatment

Inactive Publication Date: 2017-02-22
郑州莉迪亚医药科技有限公司
View PDF2 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] At present, Western medicine mainly uses the second and third generation cephalosporins, β-lactams, and fluoroquinolones for treatment. Although they have a certain effect, with the change of pathogenic microorganisms, drug resistance is becoming more and more serious, and the side effects are relatively large. It is expensive, so it is difficult to popularize widely, while traditional Chinese medicine shows great advantages in improving symptoms and signs, shortening the course of treatment and improving the overall treatment effect, but the curative effect is slow, and long-term use is harmful to the liver and kidney

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0018] A pharmaceutical composition for treating community-acquired pneumonia, the main raw materials in parts by weight are: 4 parts of ertapenem, 15 parts of allicin, 4 parts of amygdalin, 2 parts of cefixime, 3-n-butylbenzene 1 part of phthalein, 0.8 parts of 3-n-butyl-4,5-dihydrophthalide, 1.5 parts of benzenesulfonic acid hydrazine, 1 part of ampicillin, and 2 parts of swertiamarin.

[0019] A preparation method of a pharmaceutical composition for treating community-acquired pneumonia, the specific steps are:

[0020] First, in a pharmaceutical-grade clean area, weigh ertapenem, allicin, amygdalin, cefixime, 3-n-butylphthalide, 3-n-butyl-4,5-di Hydrogen phthalide, benzenesulfonic acid hydrazine, ampicillin, swertiamarin, sieve, add ultrapure water after mechanical mixing, place in a pharmaceutical mixer, mix for 4min, control RSD ≤ 5%, press into tablets after mixing and Drying at low temperature, the temperature is controlled at 4°C, and packaging is ready to obtain the...

Embodiment 2

[0022] A pharmaceutical composition for treating community-acquired pneumonia, the main raw materials in parts by weight are: 6 parts of ertapenem, 18 parts of allicin, 5 parts of amygdalin, 3 parts of cefixime, 3-n-butylbenzene 1 part of phthalein, 0.9 parts of 3-n-butyl-4,5-dihydrophthalide, 1.6 parts of benzenesulfonic acid hydrazine, 1 part of ampicillin, and 2 parts of swertiamarin.

[0023] A preparation method of a pharmaceutical composition for treating community-acquired pneumonia, the specific steps are:

[0024] First, in a pharmaceutical-grade clean area, weigh ertapenem, allicin, amygdalin, cefixime, 3-n-butylphthalide, 3-n-butyl-4,5-di Hydrogen phthalide, benzenesulfonic acid hydrazine, ampicillin, swertiamarin, sieve, add ultrapure water after mechanical mixing, place in a pharmaceutical mixer, mix for 4min, control RSD ≤ 5%, press into tablets after mixing and Drying at low temperature, the temperature is controlled at 4°C, and packaging is ready to obtain the...

Embodiment 3

[0026] A pharmaceutical composition for treating community-acquired pneumonia, the main raw materials in parts by weight are: 7 parts of ertapenem, 20 parts of allicin, 6 parts of amygdalin, 4 parts of cefixime, 3-n-butylbenzene 2 parts of phthalein, 1.0 parts of 3-n-butyl-4,5-dihydrophthalide, 1.7 parts of benzenesulfonic acid hydrazine, 2 parts of ampicillin, and 3 parts of swertiamarin.

[0027] A preparation method of a pharmaceutical composition for treating community-acquired pneumonia, the specific steps are:

[0028] First, in a pharmaceutical-grade clean area, weigh ertapenem, allicin, amygdalin, cefixime, 3-n-butylphthalide, 3-n-butyl-4,5-di Hydrophthalide, benzenesulfonic acid hydrazine, ampicillin, swertiamarin, sieved, mechanically mixed, added ultrapure water, placed in a pharmaceutical mixer, mixed for 6 minutes, controlled RSD ≤ 5%, mixed and pressed into tablets and Dry at low temperature, the temperature is controlled at 6° C., and pack to obtain the pharmac...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a medicine composition for treating community-acquired pneumonia, which is prepared from the main raw materials in parts by weight: 4 to 10 parts of ertapenem, 16 to 24 parts of allicin, 4 to 10 parts of amygdalin, 2 to 6 parts of cefixime, 1 to 3 parts of 3-n-butylphthalide, 0.8 to 1.4 parts of 3-n-butyl-4,5-dihydrophthalide, 1.5 to 1.9 parts of sulfoniazid, 1 to 3 parts of ampicillin, and 2 to 4 parts of swertiamarin. The medicine provided by the invention has the ability on treating community-acquired pneumonia, is strong in pertinence and scientific in compatibility so as to achieve the aim of comprehensive rehabilitation, treats both symptoms and root causes, and is short in treatment course, fast in effect, less in toxic and side effects, and low in cost.

Description

technical field [0001] The invention relates to the field of medicine preparation, in particular to a pharmaceutical composition for treating community-acquired pneumonia. Background technique [0002] Community-acquired pneumonia refers to infectious lung parenchyma (including alveolar wall, that is, pulmonary interstitium in a broad sense) inflammation that is induced outside the hospital, including pneumonia with a clear incubation period of pathogen infection that occurs during the incubation period after admission to the hospital. Community-acquired pneumonia is one of the common infectious diseases that threaten human health. The composition and drug resistance characteristics of its pathogens are significantly different in different countries and regions, and they are constantly changing over time. [0003] At present, Western medicine mainly uses the second and third generation cephalosporins, β-lactams, and fluoroquinolones for treatment. Although they have a certai...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/7048A61K9/20A61P11/00A61K31/255A61K31/365A61K31/407A61K31/43A61K31/4409A61K31/546A61K31/7028
CPCA61K31/407A61K9/2004A61K31/255A61K31/365A61K31/43A61K31/4409A61K31/546A61K31/7028A61K31/7048
Inventor 不公告发明人
Owner 郑州莉迪亚医药科技有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com